Abstract: A system of metalization in an integrated polymer microsystem. A flexible polymer substrate is provided and conductive ink is applied to the substrate. In one embodiment the flexible polymer substrate is silicone. In another embodiment the flexible polymer substrate comprises poly(dimethylsiloxane).
Type:
Application
Filed:
February 20, 2003
Publication date:
January 29, 2004
Applicant:
The Regents of the University of California
Inventors:
James Courtney Davidson, Peter A. Krulevitch, Mariam N. Maghribi, William J. Benett, Julie K. Hamilton, Armando R. Tovar
Abstract: Vaccines based on one or more combinations of majorly abundant extracellular products of pathogens and methods for their use and production are presented. The most prevalent or majorly abundant extracellular products of a target pathogen are selected irrespective of their absolute molecular immunogenicity and used as vaccines to stimulate a protective immune response in mammalian hosts against subsequent infection by the target pathogen. The majorly abundant extracellular products may be characterized and distinguished by their respective N-terminal amino acid, amino acid, or DNA sequences. As the vaccines may comprise different combinations of the extracellular products, subunits thereof, or encoding nucleic acids, a broad range of effective immunotherapeutic compositions are provided by the present invention. In addition to other infectious agents, the vaccines so produced can be used to stimulate an effective immune response against intracellular pathogens and in particular Mycobacterium tuberculosis.
Type:
Application
Filed:
September 14, 2001
Publication date:
January 29, 2004
Applicant:
The Regenets of The University of California
Abstract: Methods are disclosed for rapid, reliable and simple isolation of RNA from formalin-fixed paraffin-embedded tissue samples. RNA purified in this manner can be used for quantitative measurement gene expression levels. The tissue sample can be a tumor or other pathological tissue.
Type:
Application
Filed:
July 30, 2003
Publication date:
January 29, 2004
Applicant:
University of Southern California
Inventors:
Kathleen Danenberg, Peter V. Danenberg, Steven Swenson
Abstract: This invention relates to the discovery of a novel endophytic fungus, Muscodor albus, which produces volatile antibiotics that have been shown to be effective in the treatment of human and animal waste products. Through experimentation, this invention confirms that Muscodor albus can be used in disposable bags in connection with portable toilets to solve the problem of degradation of waste products in situations where humans are removed from sanitary facilities. This invention includes the discovery of non-volatile inhibitors that are also produced by Muscodor albus and that are similarly effective in treating human and animal wastes. This invention covers a unique and novel method for preparing Muscodor albus for commercial use in the treatment of human and animal wastes, which involves infesting barley seeds with Muscodor albus and then storing them under conditions that will allow the fungus to remain viable for up to nine months.
Abstract: A method and apparatus for collecting and processing physical space data used while performing image-guided surgery is disclosed. Physical space data is collected by probing physical surface points of surgically exposed tissue. The physical space data provides three-dimensional (3-D) coordinates for each of the physical surface points. Based on the physical space data collected, point-based registrations used to indicate surgical position in both image space and physical space are determined. In one embodiment, the surface of surgically exposed tissue of a living patient is illuminated with laser light. Light reflected from the illuminated surface of the exposed tissue is received and analyzed. In another embodiment, one or more magnetic fields of known shape and size are established in the proximity of the exposed tissue. Data associated with the strength of the magnetic fields is acquired and analyzed.
Type:
Application
Filed:
April 16, 2003
Publication date:
January 29, 2004
Applicant:
Vanderbilt University
Inventors:
Robert L. Galloway, William C. Chapman, James D. Stefansic, Alan J. Herline, Michael I. Miga, David M. Cash, Tuhin K. Sinha
Abstract: A method of forming a capacitor comprises: providing a first metallic thin-film layer; forming a dielectric thin-film layer of an anodized metal on a side of said first metallic layer; providing a second metallic thin-film layer on a side of the dielectric layer opposite the first metallic layer; and excising an area of the resulting structure to obtain at least one capacitor having a pair of electrode plate structures constituted by portions of said first and second metallic layers separated by a portion of said dielectric layer, and having connection points at adjacent electrode plate edges which are accessible from a same side of the capacitor and effective for operatively connecting the capacitor such that the capacitor does not exhibit an inductive resonance below a frequency of at least 1 GHz.
Type:
Application
Filed:
January 13, 2003
Publication date:
January 29, 2004
Applicant:
The Board of Trustees of the University of Arkansas
Abstract: The invention relates to the discovery of a novel amino acid sequence motif, herein termed the RKIP motif, and to the family of proteins defined by the presence of that motif. Proteins comprising the RKIP motif modulate kinases involved in signal transduction pathways. The RKIP motif forms the basis for screening assays for the identification of agents useful for modulating signal transduction pathways subject to RKIP family mediated regulation, and for the diagnosis and treatment of disorders involving inappropriate activities of pathways subject to RKIP family mediated regulation.
Type:
Application
Filed:
March 6, 2003
Publication date:
January 29, 2004
Applicant:
Brown University
Inventors:
John M. Sedivy, Walter Kolch, Kam Chi Yeung
Abstract: A backlash clutch comprising first rotation member (3) and a second rotation member (4), each of which are provided rotatably on an identical axis, and are engaged together in a rotating direction of the members by contacting each radial extension surface (3a, 4a). A gap d exists between said radial extension surface of the first and the second rotation members (3a, 4a) at the rotating direction of the members.
Abstract: This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins. In particular, transgenic avians are produced which express exogenous sequences in their oviducts and which deposit exogenous proteins into their eggs. Avian eggs that contain exogenous proteins are encompassed by this invention. The instant invention further provides novel forms of interferon and erythropoietin which are efficiently expressed in the oviduct of transgenic avians and deposited into avian eggs.
Type:
Application
Filed:
January 24, 2003
Publication date:
January 29, 2004
Applicants:
AviGenics, Inc., University of Georgia Research Foundation, Inc.
Inventors:
Robert D. Ivarie, Alex J. Harvey, Julie A. Morris, Guodong Liu, Jeffrey C. Rapp
Abstract: The present invention provides compositions and methods for producing a transgenic plant that exhibits altered characteristics resulting from over expression or under expression of a novel polypeptide PtM3 or its homolog PtM4. The altered characteristics resulting from over-expression include at least one of the ability to convert axillary meristem to floral meristem; to accelerate flowering i.e., early flowering; to increase fruit production; to increase nut production; to increase seed output; to increase branching; to increase flower production; to increase fruit yield; to increase flower yield and a combination thereof. The altered characteristics resulting from suppressed expression include at least one of complete sterility; partial sterility (sterility of only one sex of a bisexual plant); reduced pollen production; decreased flowering; increased biomass and combinations thereof.
Type:
Application
Filed:
July 26, 2002
Publication date:
January 29, 2004
Applicant:
Board of Control of Michigan Technological University
Inventors:
Gopi Krishna Podila, Leland James Cseke, Banalata Sen, David F. Karnosky
Abstract: A method of forming a stable junction on a microelectronic structure on a semiconductor wafer having a silicon surface layer on a substrate includes the following steps: implanting dopant ions into the surface layer; cleaning and oxidizing the surface layer, and twice annealing the wafer to recover a damaged silicon crystal structure of the surface layer resulting from the low energy ion implantation. The first annealing process uses a temperature range of 800° C. to 1200° C. for a duration from about a fraction of a second to less than about 1000 seconds, with a ramp-up rate of about 50° C./second to about 1000° C./second. The second annealing process uses a temperature range of 400° C. to 650° C. for a time period of from about 1 second to about 10 hours, and more preferably, from about 60 seconds to about 1 hour. Both annealing processes include cooling processes.
Abstract: Fabrication of silicon thin film transistors (TFT) on low-temperature plastic substrates using a reflective coating so that inexpensive plastic substrates may be used in place of standard glass, quartz, and silicon wafer-based substrates. The TFT can be used in large area low cost electronics, such as flat panel displays and portable electronics such as video cameras, personal digital assistants, and cell phones.
Type:
Application
Filed:
July 16, 2003
Publication date:
January 29, 2004
Applicant:
The Regents of the University of California
Inventors:
Jesse D. Wolfe, Steven D. Theiss, Paul G. Carey, Patrick M. Smith, Paul Wickboldt
Abstract: RNA interference using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR inhibit expression of these genes. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering the small interfering RNAs.
Type:
Application
Filed:
November 14, 2002
Publication date:
January 29, 2004
Applicant:
The Trustees of the University of Pennsylvania
Inventors:
Michael J. Tolentino, Samuel Jotham Reich
Abstract: High-performance intermediate temperature solid oxide fuel cells (SOFCs). The SOFCs are ceria-based structures that can achieve a power output of 300 mW/cm2 at an operating temperature below 600° C. By way of example, the fuel cell as an anode made of NiO/doped-ceria, a thin film of doped-ceria and/or doped zirconia electrolyte is deposited on the anode, and a cathode of cobalt iron based material, such as (La, Sr)(Co, Fe)O3 is deposited on top of the electrolyte, and can operate at a temperature of 550° C. The various layers may be deposited by colloidal spray deposition or aerosol spray casting.
Type:
Application
Filed:
January 24, 2003
Publication date:
January 29, 2004
Applicant:
The Regents of the University of California
Abstract: The present disclosure provides methods for enhancing the response of a patient's immune system to vaccination. This is accomplished by reactivating the thymus. Optionally, hematopoietic stem cells, autologous, syngeneic, allogeneic or xenogeneic, are delivered to increase the speed of regeneration of the patient's immune system. In one embodiment the hematopoietic stem cells are CD34+. The patient's thymus is reactivated by disruption of sex steroid mediated signaling to the thymus. In one embodiment, this disruption is created by administration of LHRH agonists, LHRH antagonists, anti-LHRH receptor antibodies, anti-LHRH vaccines or combinations thereof.
Abstract: The object of this invention is to provide a novel protein that is an Al-activated malate transporter of a plant, and to provide a gene encoding the protein. To deal with this object, present invention provides ALMT1-1 gene, a novel gene derived from wheat, and ALMT1-1 protein encoded by the gene. The ALMT1-1 protein is a protein functioning as aluminum-activated malate transporter. As malate forms complex with Al to inactivate the Al ion, the ALMT1-1 protein is involved in Al tolerance of a plant. Therefore, Al tolerance can be rendered to a plant using the ALMT1-1 gene that encodes the ALMT1-1 protein.
Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
Type:
Application
Filed:
January 24, 2003
Publication date:
January 29, 2004
Applicant:
University of Pittsburgh
Inventors:
Anthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
Abstract: The present invention provides a Schottky Structure in gallium arsenide (GaAs) semiconductor device, which comprises a gallium arsenide (GaAs) semiconductor substrate, a titanium (Ti) layer on a surface of said gallium arsenide (GaAs) semiconductor substrate to form Schottky contact, a diffusion barrier layer on a surface of said titanium (Ti) layer to block metal diffusion, and a first copper layer on a surface of said diffusion barrier layer.
Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
Type:
Application
Filed:
May 27, 2003
Publication date:
January 29, 2004
Applicant:
The Regents of the University of California
Inventors:
Robert E. Reiter, Owen N. Witte, Douglas C. Saffran, Aya Jakobovits